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reveals the importance of oxidative stress
response in Saccharomyces cerevisiae clinical
strains
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M Teresa Fernández-Espinar1 and Roberto Pérez-Torrado1*Abstract
Background: In recent years an increasing number of yeast infections in humans have been related to certain
clinical isolates of Saccharomyces cerevisiae. Some clinical strains showed in vivo and in vitro virulence traits and
were able to cause death in mice whereas other clinical strains were avirulent.
Results: In this work, we studied the transcriptional profiles of two S. cerevisiae clinical strains showing virulent traits
and two control non-virulent strains during a blood incubation model and detected a specific transcriptional
response of clinical strains. This response involves an mRNA levels increase of amino acid biosynthesis genes and
especially oxidative stress related genes. We observed that the clinical strains were more resistant to reactive
oxygen species in vitro. In addition, blood survival of clinical isolates was high, reaching similar levels to pathogenic
Candida albicans strain. Furthermore, a virulent strain mutant in the transcription factor Yap1p, unable to grow in
oxidative stress conditions, presented decreased survival levels in human blood compared with the wild type or
YAP1 reconstituted strain.
Conclusions: Our data suggest that this enhanced oxidative stress response in virulent clinical isolates, presumably
induced in response to oxidative burst from host defense cells, is important to increase survival in human blood
and can help to infect and even produce death in mice models.
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S. cerevisiae is a ubiquitous organism that can be found
in nature on plants, fruits and in soil. This species is
involved in fermentative processes in beer, bread and
wine, and is even consumed as a nutritional supplement,
always being traditionally regarded as absolutely safe. S.
cerevisiae and its commercially available preparations
known as Saccharomyces boulardii, that are used to treat
antibiotic-related diarrhea, have recently been shown to
have the potential to cause a wide variety of infections,
ranging from cutaneous infections and vaginitis in* Correspondence: rober@iata.csic.es
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reproduction in any medium, provided the orhealthy patients to systemic infections of the blood-
stream and vital organs in immunocompromised and
critically ill patients [1-3]. The patients infected are
mainly premature children, elderly people or patients
suffering from immunosuppression due to AIDS, treat-
ment with immunosuppressive agents, and other condi-
tions associated with an insufficient immune response.
Moreover, severe infections by S. cerevisiae have been
occasionally reported in patients with no obvious predis-
posing factors [4,5].
Some S. cerevisiae clinical strains have been isolated
from blood [4,6-8]. The main routes for bloodstream
infections are probably translocation of ingested yeast
from the gut or direct contamination of the central ven-
ous catheter insertion site [9-11]. Similarly to othertd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ability to colonize and cause disease in the host depends
on the immune status of the host and the expression of
certain virulence factors by the pathogen [12,13]. The
majority of S. cerevisiae clinical isolates secrete high
levels of proteases and phospholipases, can grow at
42°C, exhibit multiple colony phenotypes, have ability to
adhere to epithelial tissue and show invasive pseudohy-
phal growth on solid agar [9,14-16]. These studies
showed that clinical isolates differed phenotypically from
laboratory and wine strains in vitro, but it remains un-
clear whether these traits also play a role during infec-
tion. Comparison of S. cerevisiae clinical and non-
clinical strains by molecular typing and determination of
putative virulence traits has not revealed a specific viru-
lence factor that clearly separates the strains of clinical
origin from the strains of non-clinical origin [17,18]. In
addition, little is known about the interactions between
S. cerevisiae and host defence cells or non-cellular com-
ponents [18].
mRNA level profiles of clinical strains of S. cerevisiae
following exposure to whole blood rather than serum
may closely reflect the in vivo response of these yeasts
during bloodstream infections, since C. albicans expres-
sion profiles following intravenous infection of mice
closely resembled profiles following incubation in whole
blood [19], which in turn strongly correlated with the
expression profile of C. albicans exposed to neutrophils
[20]. In these studies, the authors identified differentially
expressed C. albicans genes involved in general stress re-
sponse, antioxidative response, the glyoxylate cycle as
well as putative virulence genes expressed in response to
human blood cells [19].
To better understand the physiology of virulent S. cer-
evisiae cells during infection, we performed a transcrip-
tional analysis to investigate which genes and pathways
are required for survival in blood as a model of human
bloodstream infection. We compare two control non-
virulent strains with two virulent isolates (60 and D14).Table 1 Significant functional groups observed in up-regulate
for virulent (60, D14) and non-virulent (CECT 10431, W303) s
Functional groups
15
60 CECT 10431 W303 D14 60
Translation + + - + +
Ribosome biogenesis + + - + +
Gene expression + + - + +
Amino acid biosynthetic process + - - - +
Aspartate family amino acid
biosynthetic process
- - - - +
Arginine biosynthetic process - - - - +
aFunctional groups were (+) or were not (−) significantly overrepresented (p-valuesThese strains showed the highest levels in virulence fac-
tors, were able to colonize immunocompetent mice
brain after blood infections and cause mice death, show-
ing increased adherence ability whereas other clinical
isolates showed low virulence levels [3,18]. Comparison
of control and virulent strains revealed that amino acid
biosynthesis and elevated oxidative stress response can
be of special relevance for survival of S. cerevisiae viru-
lent strains to host defences. Phenotypic analysis of viru-
lent strains and a YAP1 mutant, unable to respond to
oxidative stress, confirmed the importance of the
increased oxidative stress response for yeast survival in
human blood incubations.
Results
Transcription profile of yeasts in human blood
To obtain a global view of the S. cerevisiae response to
blood environment and to investigate which set of genes
are expressed in the different yeast, we analyzed the tran-
scription profile of avirulent (W303 and CECT 10431)
and virulent (D14 and 60) strains exposed to blood. We
incubated yeast cells in human blood using the model pre-
viously established by Fradin et al. [19] and searched for
significantly over-represented functional groups in up-
regulated (Table 1) or in the down-regulated (Table 2) set
of genes during the time course of the experiment (Genes
and significances are presented in Additional file 1: Table
S1 and Table S2). A complete microarray dataset is pre-
sented in Aditional file 2: Table S3.
YPD precultured cells were preadapted in PBS buffer
before inoculation in human blood [19]. Preadapted cell
suspension was inoculated into fresh whole human blood
and incubated for 0, 15, 30 and 60 min at 37°C. mRNA
levels was determined by microarray hybridization. The
arrays were hybridized with each time point and the time
point 0 min for each strain, thus, mRNA level data for 15,
30 and 60 min reflects the induction respect time 0. Data
were ratio-based normalized and a FDR of 5% was used to
identify statistically significant data. The microarrayd genes after 15, 30 and 60 min of incubation in blood
trains a
Time (min)
30 60
CECT 10431 W303 D14 60 CECT 10431 W303 D14
+ - + + + - +
+ - + + + + +
- - + + + - +
+ - + + + - +
+ - + + - - -
+ - + + - - -
< 0.05).
Table 2 Functional groups observed in down-regulated genes after 15, 30 and 60 min of incubation in blood for
virulent (60, D14) and non-virulent (CECT 10.431, W303) strains a
Functional groups Time
15 30 60
60 CECT 10431 W303 D14 60 CECT 10431 W303 D14 60 CECT 10431 W303 D14
Protein folding - + + - - - + - - + - -
Oxidative phosphorylation - - - - - + - - - + - -
Glutamate biosynthetic process - - - - - - - - - - - +
aFunctional groups were (+) or were not (−) significantly overrepresented (p-values < 0.05).
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of three biological replicates including a dye swap. A
complete set of data for all genes is included in Additional
file 2: Table S3. Data was validated measuring mRNA
levels of 7 genes by qRT-PCR in different strains and con-
ditions (Additional file 1: Table S4) showing that induc-
tions or repressions differ less than 20% between the two
methods.
First, we searched in the data for significantly repre-
sented functional groups in up-regulated (Table 1) or in
the down-regulated (Table 2) set of genes (Bonferroni
corrected p-values < 0.05). After 15 min of blood incuba-
tion, three functional groups (Translation, Biogenesis of
ribosome and Gene expression) were found in the
induced set of genes in all strains except for the labora-
tory strain W303. These significantly represented func-
tional groups that comprise genes related with normal
vegetative growth, appeared in the up-regulated genes
during all the experiment, except time point 0 min, indi-
cating a continuous adaptation of these strains to the
blood environment. For strain W303, the functional
group Ribosome biogenesis was significant only after
60 min of incubation, revealing a delayed adaptation to
the new environment. Strains CECT 10431, 60 and D14
showed no differences in this set of functional groups.
Genes belonging to these functional groups include ribo-
somal protein genes such as RPL32 and RPS10, transla-
tional elongation factor genes such as TEF2 and EFB1,
and tRNA synthetase genes such as THS1.
The functional group Amino acid biosynthetic process
was observed in strain 60 at time point 15 min and in
strains 60, D14 and CECT 10431 after 30 and 60 min.
Furthermore, the functional groups Aspartate family
amino acid biosynthetic process and Arginine biosyn-
thetic process were significant for strain 60, D14 and
CECT 10431 at 30 min and for strain 60 at the last time
point (60 min).
Some functional groups were found to be significantly
repressed (Table 2). Protein folding was observed in CECT
10431 after 15 min of incubation and during the entire
time course in W303, but not in the virulent strains 60
and 14. The main function of the genes included in this
group, such as SSA2, is to encode molecular chaperones,which bind newly-translated proteins to assist proper
folding and to prevent aggregation/misfolding [21]. The
down regulation of genes of this functional group in
W303 is consistent with the observed delay in the func-
tional groups related to preparation for growth like
Ribosome biogenesis. In the down-regulated set of genes,
the functional group Oxidative phosphorylation was
observed in strain CECT 10431 after 30 and 60 min
and the functional group Biosynthesis of glutamate was
detected at 60 min. No significant functional group was
observed in the down-regulated genes in virulent strains
60 and D14.
On the other hand, we found significant changes in
the mRNA levels of specific genes implicated in import-
ant biological process (see Additional file 2: Table S3).
At the early stage (15 min), several genes encoding
glycolytic enzymes were up-regulated. The genes encod-
ing glucose-6-phosphate isomerase (PGI1), phosphofruc-
tokinase (PFK2) and aldolase (FBA1) were up-regulated
at early stages of incubation, but the mRNA levels were
even higher after 30 min and 60 min for wine strain
CECT 10431 and D14 respectively. For strain 60, the
maximal mRNA level was monitored after 60 min. For
the laboratory strain W303, the mRNA level of all three
genes was down-regulated at 15 min, PGI1 was weakly
induced at 30 min, and PFK2 mRNA level was up-
regulated at 60 min. In strain 60, other genes that en-
code glycolytic enzymes were mostly down-regulated in
the early stages compared to 0 min time point, but tran-
scripts were considerably elevated at the later stages of
the incubation, such as, glyceraldehyde 3-phosphate de-
hydrogenase (TDH3), phosphoglycerate kinase (PGK1)
and enolase (ENO1). Also, the mRNA level of gluconeo-
genic enzyme phosphoenolpyruvate carboxykinase
(PCK1) was strongly down-regulated in this strain.
The genes encoding the key enzymes of the glyoxylate
cycle, isocitrate lyase (ICL1) and malate synthase (MLS1)
were down-regulated in all strains during the time
course of the experiment, although this repression was
less strong at the later stage in strains D14 and 60. These
genes are subjected to catabolite repression which sug-
gests that yeast cells have access to glucose during all
the experiment.
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virulent strains in human blood
To identify genes specifically expressed in S. cerevisiae
virulent isolates in blood, we analyzed the mRNA levels
at different incubation times and we identified statisti-
cally significant data when comparing average of virulent
strains group (60 and D14) data with average of non-
virulent group (W303 and CECT 10431) data. Then we
searched for functional groups of genes whose mRNA
level was specifically associated with virulent strains of
S. cerevisiae (Table 3).
After 15 min of blood incubation, three functional
groups were significantly overrepresented in the up-
regulated set of genes in virulent strains compared to
non-virulent strains: Vacuole organization, Xenobiotic
transporter and Base-excision repair. The functional
group Vacuole organization, induced again after 30 min,
includes genes related with biogenesis, protein-vacuolar
targeting and vacuole fusion (CUP5, VPS3 and VTC1).
The Base-excision repair pathway removes lesions that
result from exposure to endogenous or exogenous react-
ive oxygen species (ROS) [22] and includes genes such
as POL30 (DNA polymerase processivity factor), RAD27
(5' flap endonuclease), APN1 (DNA apurinic or apyrimi-
dinic site lyase) and OGG1 (purine-specific oxidized base
lesion DNA N-glycosylase). The level of mRNA of these
genes decreased along the experiment in virulent strains.
Seven functional groups more were enhanced at time
points 30 or 60 min in virulent strains. Four closely
related groups (Amino acid biosynthetic process, Amino
acid metabolic process, Amine biosynthetic process and
Nitrogen compound biosynthetic process) include genes
that take part in the biosynthesis of some aminoacids,Table 3 Functional groups observed in up-regulated genes in
60 min of incubation in blood a
Functional groups Time (min)
15 30 60
Base-excision repair + - - POL3
Vacuole organization + + - CMD
VTC3
Xenobiotic transporter + - - PDR5
Amino acid biosynthetic process/ Amine biosynthetic
process/ Nitrogen compound biosynthetic process
- + + ARO4
ARG1
Amino acid metabolic process - + + ADH5
LYS1/
Phosphatase activity - + + PTC3
TSL1/
Transmembrane transporter activity - + - CTP1
VMA5
YMC1
Cell redox homeostasis - - + TTR1
UBA1
a Functional groups were (+) or were not (−) significantly overrepresented (p-valuessuch as aromatic aminoacids (ARO3, ARO4), histidine
(HIS1, HIS5), arginine (ARG1, ARG5, ARG6, ARG8),
tryptophan (TRP3), lysine (LYS1, LYS4), leucine (LEU9),
and serine (SER3, SER33). We wanted to know if the
presence of several auxotrophies in the laboratory strain
W303 could indirectly affect the appearance of func-
tional groups related to aminoacid metabolism in this
analysis. We repeated the data analysis comparing the
two virulent strains (D14 and 60) against the wine strain
CECT 10431, excluding W303 strain. The results
showed once again the appearance of aminoacid metab-
olism functional groups as Cellular aminoacid metabolic
process, containing similar genes as (LEU9, SER3, ARG1,
ARG8). Then we concluded that W303 auxotrophies are
not biasing the results, probably because the short time
sampling, and that aminoacid metabolism related genes
are highly activated in the clinical isolates. The fifth
functional group, Phosphatase activity, includes genes
such as PHO3, PHO5 and PHO12 that are expressed
under low-phosphate conditions. It may indicate a re-
sponse to phosphate starvation during blood incubation.
Also, PHO3 is able to hydrolyze thiamin phosphates in
the periplasmic space, increasing cellular thiamine up-
take. Another functional group is Transmembrane trans-
porter activity which includes genes that take part in the
mitochondrial transport (CTP1, YHM1), zinc transport
(ZRT1) and amino acid transport (GNP1).
A key functional group, Cell redox homeostasis, was
found to be enhanced during the incubation in blood
in virulent strains. The genes belonging to this group
help to maintain a reduced environment in the cell
and are associated with virulence in bacteria [23-25].
These genes play a significant role in defending thevirulent strains related to control strains after 15, 30 and
Genes
0, POL31, RAD27, APN1, OGG1
1, VPS3, CUP5, VTC1, SFK1, VID24/ MD1/ VPS45/ TRX2/ TRX1/ VAC7/ TPM1/
/
, SNQ2, PDR12
/ ARO3/ LYS4/ HIS1/ ARG5/ARG6/ SER3/ILV1/ SER33/ HIS5/ LYS1/ TRP3/
/ ARG8/ LEU9/ ORT1/ SAM4
/ ARO4/ ARO3/ LYS4/ HIS1/ ARG5/ARG6/ SER3/ ILV1/ADH4/ SER33/ HIS5/
URA2/ TRP3/ MSE1/ ARG1/ ARG8/ LEU9/ ORT1/ SAM4/
/ PHO3/ PHO5/ DPP1/ LPP1/ SDT1/ PHO12/ INP51/ SAP185/ SAC1/ PPZ1/
YMR087WTPS3/ FCP1/ YNL217W/ PHO12
/ GGC1/ ATP17/ GNP1/ PIC2/ HXT10/ VPS73/ ZRT1/ TPO2/ TNA1/ AVT1/
/ ZRT3/ YBT1/ AQY2/ SMF3/ ZRT2/ ATR1/ ITR2/ ORT1/ ODC2/ PDR12/
/ ANT1/ TPO3/
/ TRX2/ TRX1/ TSA1/ GLR1/ YNL134C/ TPS1/ PGM2/ GRE2/ MXR1/ PDI1/
/ LYS20/ AHP1/ TKL1/TAL1/ ADH6/ CYS3
< 0.05).
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species (ROS), integral effectors of mammalian host
defenses. Stimulated leucocytes can be a source of
ROS, which may cause oxidative stress. Defense against
this stress seems to be enhanced at 60 min of incuba-
tion of blood. Indeed, when we observed oxidative
stress related genes, most of them (17) show statisti-
cally significant higher levels in virulent strains com-
pared to non-virulent strains (Figure 1). On average, a
very significant (p < 0.005) increase (0.20 to 1.43) is
observed in the virulent strains respect to non-virulent
strains. Interestingly, all the 17 genes are regulated by
Yap1p, the main regulator of oxidative stress in yeasts
(http://www.yeastract.com). Several components of the
thioredoxin system are included in this set of genes. A
thioredoxin peroxidase (TSA1) and two thioredoxin
genes (TRX1 and TRX2) were strongly upregulated in
virulent strains at time 60 min. Also mRNA levels of
TRR1, a thioredoxin-disulfide reductase gene, increase
during the incubation in blood in strains 60 and D14.
Only the Pyridoxine metabolic process functional
group was downregulated with regards to non-virulent
strains at time point 30 min. This group includes genes
(SNZ, SNO2) involved in pyridoxine metabolism and
thiamine biosynthesis.Resistance to oxidative stress of virulent and non-virulent
strains
To confirm the relevance of the oxidative stress response
on the virulent nature of yeast strains we measured the-2
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Figure 1 Expression levels of oxidative stress related genes comparin
human blood. Induction of oxidative stress related genes in non-virulent (
All genes showed significantly different (p<0.05) values between the two g
errors 6 are shown.percentage of survival of these four strains after one
hour in the presence of elevated levels (6 mM) of H2O2
(Figure 2). Virulent isolates exhibited higher survival rates
whereas W303 and CECT 10431 showed very low sur-
vival. Statistical analysis confirmed significant differences
in oxidative stress between virulent and non-virulent
strains (p < 0.0005) whereas no significant differences be-
tween CECT 10431 and W303 or 60 and D14 were found
(Additional file 1: Table S5).Survival of yeast strains in human blood
The aim of this experiment was to study the survival of
control and pathogenic S. cerevisiae strains comparing
them with C. albicans and also to know which blood cell
types are affecting more yeast self-preservation. In this
experiment S. boulardii strain Ultralevure, a bio-
therapeutic agent which has been described as a poten-
tial pathogenic [6,9,10], was included. To investigate the
survival of the different strains, we incubated the cells
10 min and 1 hour at 37°C in human blood (Table 4).
We observed that after 10 min the virulent strains
D14 and 60 showed survival levels similar to the patho-
genic C. albicans strain SC5314. In contrast, control
strain W303 presented significantly lower survival. After
60 min of incubation the survival of all strains
decreased. However we observed again a similar pattern
since strains 60 and D14 showed comparable values to
virulent SC5314 whereas W303 presented significantly
lower survival. S. boulardii strain showed similar values
to the C. albicans strain in this assay. The wine strain Virulent strains
GRE2 MXR1
TRX1 LYS20
TAL1 TSA1
g virulent and non-virulent strains after 60 min of incubation in
CECT 10431 and W303) or virulent strains (D14 and 60) was averaged.
roups using Student’s t-test statistical analysis. Average and standard
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Figure 2 Survival percentages comparison of virulent and non-
virulent strains after oxidative stress. The different strains were
exposed to 6 mM H2O2 for 1 hour and then plated in YPD media for
colony counting. Percentages were calculated comparing with
untreated cells. Averages and standard errors of independent
triplicates are shown.
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http://www.biomedcentral.com/1471-2164/13/419CECT10431 also presented survival levels lower than C.
albicans and virulent S. cerevisiae strains but data was
not significant.
A virulent strain mutant in Yap1p showed decreased
survival in human blood
To confirm that oxidative stress response of virulent
strains is important to survive in human blood we
decided to study performance of a strain unable to grow
in oxidative stress conditions. Since all genes with
increased mRNA levels in virulent strains observed in
Figure 1 are regulated by the transcription factor Yap1p,
we decided to study survival in human blood comparing
the wild type strain D14 with a homozygous for a Δ
yap1 mutation. First we confirmed that D14Δyap1 was
unable to survive in the presence of oxidative stress con-
ditions (2.5 mM H2O2) whereas the wild type strain pre-
sented no growth defects (Figure 3A). Reincorporation
of YAP1 in D14YAP1 strain reverted this phenotype.
This experiment confirmed that Yap1p is essential to
perform a proper oxidative stress response in virulent
strains. Then we evaluated the behavior of the
D14Δyap1 strain in human blood incubation assay.
Using the same conditions described above, yeast cells
were added to blood and survival was determined
after 0, 30, 60 and 90 min (Figure 3B). The resultsTable 4 Yeasts survival in human blood incubations a
Species C. albicans S. cerevisiae S. cerevisia
Strain SC5314 60 D14
Time (min)
10 87.4 ± 8.7 98.8 ± 8.7 76.5 ± 13.8
60 56.4 ± 3.7 56.4 ± 3.7 60.5 ± 5.8
a Survival is expressed as% of cfu respect time 0. *Strains individually compared toshowed that D14Δyap1 survival decreased significantly
(p-value < 0.05 at 30 or 60 and p-value < 0.01 at 90 min
time points) reaching a level comparable to that of the
laboratory strain W303 at 60 min (Table 4), confirming
the relevance of a proper oxidative stress response
to survive in human blood. Again, D14YAP1 showed
similar phenotype than the wild type, confirming the
involvement of Yap1p in blood survival.
Discussion
Blood is a complex milieu composed of several types of
immunoactive cells and molecules. As we have previ-
ously observed, several clinical strains of S. cerevisiae
adapt to blood environment and are able to survive and
spread to other tissues in murine models. To better
understand the response of S. cerevisiae to this complex
environment and to search for special features of viru-
lent strains we have analysed the transcriptome of S. cer-
evisiae cells after contact with human blood. The results
showed that they express several groups of genes in
order to rapidly accommodate to this special environ-
ment. As expected, a high mRNA level of genes encod-
ing factors involved in protein synthesis were detected
in every strain after 15 min inoculation in blood, except
for the laboratory strain W303. The strong induction of
these set of genes is probably a consequence of the yeast
cells transfer from nutrient poor medium (PBS) to a
relatively nutrient-rich medium (blood). The downregu-
lation of PCK1, encoding the gluconeogenic enzyme
phosphoenolpyruvate carboxykinase, and other genes
supports that yeast cells are exposed to a carbohydrate-
rich environment, even at the later stages of incubation
in blood, when most of the yeast cells are phagocytized.
In C. albicans, a high level of different transcripts
involved in protein synthesis was also detected at the be-
ginning of the incubation in blood, but the mRNA level
of these genes decreased during the incubation [19], in-
dicating that growth initiation occurred only in the early
stages. This suggests that C. albicans has a faster re-
sponse to adapt to blood environment than S. cerevisiae.
We observed that the induction of genes involved in
aminoacid biosynthetic pathway is present during the
middle and the later time course in the virulent strains,
while in non-virulent strains they appear later or don’t
appear. Also, following exposure to human neutrophilse S. boulardii S. cerevisiae S. cerevisiae
Ultralevure CECT 10431 W303
76.0 ± 13.8 - 66.0 ± 11.2*
60.0 ± 5.8 50.8 ± 9.8 35.7 ± 4.8*
C. albicans SC5314 strain presented p< 0.05.
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Figure 3 Implication of Yap1p transcription factor in human blood yeast survival. In panel A, the strain D14 and a YAP1 mutant were
plated in YPD or YPD with 2.5 mM H2O2. In panel B, blood survival assay is shown for wild type D14 and YAP1 mutant strain. Yeasts were
inoculated 1:1 ratio respect leucocytes and yeast survival was followed for 1.5 hours by plating in YPD agar plates. Data corresponds to average
and standard errors of three independent biological replicates.
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gulate amino acid biosynthetic genes [20,26]. Rubin-
Bejerano et al. [26] observed an induction of these path-
ways after yeast cells were ingested by neutrophils, but it
was not present when yeast cells were ingested by
human monocytes. It may suggest that the microenvir-
onment in the phagosome inside the neutrophil is
deficient in amino acids and it generates a rapid re-
sponse from the virulent S. cerevisiae strains. However,
non-virulent strains are slower or less efficient in the
adaptation to this microenvironment, decreasing their
possibilities to survive. In addition, the methionine and
arginine biosynthetic genes are not induced when S. cer-
evisiae is phagocytized by the murine macrophage-like
cell line J774A [27]. Additionally, Kingsbury et al. [28]
revealed the relevance of amino acid biosynthesis for
yeast survival in murine host; however processes import-
ant for sensing and responding to quality and concentra-
tion of nitrogen compounds were not required for yeast
survival in vivo, indicating that yeast can use a variety of
nitrogen sources in these conditions. The pyridoxine
metabolic process genes were downregulated in the viru-
lent strains with regards to non-virulent strains. Padilla
et al. [29] observed that these genes were expressed
under nutrient limitation, so it may reflect that strains
60 and D14 were not exposed to a limitation of specific
nutrients, such as nitrogen.
The glyoxylate cycle is induced upon phagocytes in-
gestion of the bacteria Mycobacterium tuberculosis [30]
and other fungi such as C. neoformans [31], C. albicans
[27], Leptosphaeria maculans [32] and S. cerevisiae [27].
This shift in metabolism has been interpreted as aresponse to the glucose-poor environment of the macro-
phage, and the ability to make that shift appears to con-
tribute to the virulence of some pathogens. However, in
our condition using complex blood medium, the genes
encoding the principal enzymes of the glyoxylate cycle,
isocitrate lyase (ICL1) and malate synthase (MLS1), were
downregulated during the time course, although this re-
pression was less strong at the later stage in strains D14
and 60. This suggests that yeast cells have access to glu-
cose during almost all the experiment. The fact that
icl1Δ mutants were only slightly deficient in vivo [33]
suggests that the glyoxylate cycle has a minor contribu-
tion to S. cerevisiae fitness in vivo. The ICL1 gene of
both S. cerevisiae and C. albicans has recently been
shown to be substantially induced upon exposure to
macrophages in vitro [27,34]. However, these experi-
ments were performed with murine macrophages in cell
culture medium, where glucose concentration may be
different from blood. Furthermore, a C. albicans icl1Δ/
icl1Δ mutant showed a substantial reduction in viru-
lence [27], while the same mutant was not attenuated in
survival in blood [20], suggesting that the ICL1 gene
may play a general role when C. albicans has left the
bloodstream. All these data suggest that the ICL1 gene
may play also a general role in S. cerevisiae in human
infections but after yeast cells has left the bloodstream.
When we compared the transcriptomes of virulent
and control strains, we observed several specific groups
of genes that may explain the pathogenic nature of the
virulent strains. An interesting functional group of up-
regulated genes during blood incubation was Cell redox
homeostasis. We confirmed that this increased oxidative
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of virulent strains in pro-oxidant environments since
they have significantly much higher survival in the pres-
ence of high concentrations of H2O2. Furthermore, they
survive to oxidative burst attack from blood cells signifi-
cantly better than control strain W303 and at similar
levels that pathogenic C. albicans. The decreased sur-
vival of YAP1 mutant strain in human blood incubations
highlights the importance of the genes included in the
Yap1p regulon in determining the virulence of S. cerevi-
siae strains.
Since we have used a molecular transcriptomic ap-
proach and human blood media, it was difficult to use
several virulent and non-virulent strains, in order to ob-
tain a broad comparative view. However, Diezmann and
Dietrich [35] compared hundreds of clinical isolates due
to the use of easy tractable phenotypical assays. In con-
cordance with our results, Diezmann and Dietrich [35]
showed that S. cerevisiae clinical isolates were more re-
sistant to oxidative stress. This data suggest a correlation
between survival in oxidative stress and yeast pathogen-
icity and strongly supports our data. Macrophages, neu-
trophils and other phagocytic cells generate potent
reactive oxygen and nitrogen species (ROS and RNS),
which are toxic to most fungal pathogens, causing dam-
age to DNA, proteins and lipids [36]. Fungal pathogens
display different degrees of resistance to the reactive
oxygen and nitrogen species used by human cells to
counteract infection [37]. Fungal resistance to ROS
offers protection from oxidative host defenses and is un-
doubtedly an advantageous pathobiological property
[38,39]. It is worth mentioning that several genes
belonging to the thioredoxin system were upregulated,
which suggests its implication in yeast defense against
blood defenses. Indeed, the thioredoxin system of C.
albicans has been shown to be expressed during growth
in human blood or mucosal tissue [19,20,40], indicating
that ability to respond to oxidative stress might be cru-
cial in the early stages of systemic C. albicans infections.
Also, TRX1 is necessary for survival of C. neoformans in
the oxidative environment of macrophages and import-
ant for virulence of this fungal pathogen [41]. TSA2 and
GPX2 genes have been shown to be induced in S. cerevi-
siae strains when exposed to neutrophils [26], and a
clear antioxidant response has been observed. Fradin
et al. [20] demonstrated that neutrophils play a key role
in bloodstream infections with C. albicans. This observa-
tion is in line with the high susceptibility of neutropenic
patients (deficient in these immune cells) to dissemi-
nated candidiasis [42,43].
In conclusion, this work supports the view that oxida-
tive stress response of S. cerevisiae strains has a special
importance for survival in blood, having a high impact
in determining their virulence. This characteristic canhelp these yeasts to prevail in immunocompromised
patients and cause systemic infections.
Conclusions
In the present work we have found significant
differences at molecular level between S. cerevisiae non-
virulent strains and virulent clinical strains with remark-
able capabilities of infect and even produce mice death.
Transcription analysis in blood incubations pointed out
an enhanced oxidative stress response of virulent strains
that is reflected in an increased ability to survive in the
presence of high concentrations of the oxidant H2O2. In-
deed, they are able to survive to a similar extent than
pathogenic C. albicans strain in blood incubations.
These data suggest that S. cerevisiae virulent strains are
able to extend the survival after the macrophage oxida-
tive burst attack, having more chances to persist and
perform systemic infections.
Methods
Strains and media
Several S. cerevisiae isolates were used in this work: a
clinical isolate from vagina (isolate 60) [7], a brewer’s
strain isolated from a commercial nutritional comple-
ment product (D14) [18], and two control strains: (one
laboratory strain W303 (MATa; ura3-52; trp1Δ2; leu2-
3,112; his3-11; ade2-1; can1-100) and a wine strain
CECT 10431) [18]. Isolate 60 and D14 were chosen from
a virulent yeast collection obtained from several sources
because they have the highest levels in virulence factors
and because they were able to survive and colonize the
brain of immunocompetent mice after blood infections
and cause mice death, showing increased adherence abil-
ity [3,18]. Also, they were phagocytosed by macrophages
with less efficiency than CECT 10431 [18]. The natural
wine strain CECT 10431 was used as negative control
because it is unable to proliferate in any organ after its
intravenous inoculation in murine systems [3,18]. Sac-
charomyces cerevisiae var. boulardii commercial pre-
parations also known as Ultralevure were used in blood
survival experiments. C. albicans SC5314 [44] was used
as a positive control yeast in blood incubations. S. cerevi-
siae and C. albicans strains were cultured in YPD
medium (1.0% yeast extract, 1.0% Bacto-peptone and
2.0% glucose) prior to blood incubations.
The mutant D14Δyap1 strain was obtained using a
PCR-based gene-replacement strategy using a deletion
cassette containing geneticin resistance amplified from
pUG6 plasmid [44]. The primers used are included in
the Additional file 1: Table S6. These primers had be-
tween 40 homologous bases to the ends of the gene cod-
ing sequence. The amplified PCR product was used for
yeast modification by homologous recombination fol-
lowing yeast transformation using the lithium acetate
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plate were as follows: 2 min at 94°C; 30 cycles of 15 s at
94°C, 30 s at 50°C, 2 min at 72°C and 5 min at 72°C.
Cells were transformed with the PCR product using the
LiAc protocol (http://home.cc.umanitoba.ca/~gietz/).
After heat shock, cells were incubated for 3 hours in
YPD liquid medium at 30°C. Finally, transformed cells
were selected on YPD plates with geneticin (200 mg/L).
Geneticin resistance was removed by transforming with
pSH47, a plasmid containing Cre recombinase, inducing
in galactose for 24 h and selecting colonies without
geneticin resistance. Since D14 strain is diploid, the sec-
ond YAP1 gene deletion was performed with the same
procedure but using a replacement cassette containing
hygromycin B resistance amplified from pAG32 plasmid
[45]. The YAP1 gene deletion was confirmed by PCR
analysis and resistance to H2O2. The strain D14YAP1
was obtained by transforming D14Δyap1 strain with a
plasmid containing a wild type copy of YAP1 (pYAP1)
and selecting in YPD with 200 μg/mL of G418 (Sigma).
The plasmid obtained from Kuge et al. [46] was marker
swapped for KANMX by homologous recombination
using a cassette obtained by PCR and using pUG6 plas-
mid as a template.
Human blood incubations
Yeast cells were precultured overnight in YPD medium
at 30°C. Cells were counted and preadapted in PBS buf-
fer at a density of 2.5 x 109 cells/ml (corresponding to
two cells per leukocyte) incubating 30 min at 37°C be-
fore inoculation in human blood [22]. Human peripheral
venous blood was obtained with signed informed con-
sent under protocols approved by the bioethics commis-
sion of Centro Superior de Investigaciones Científicas.
Human peripheral venous blood was collected from
healthy volunteers by venipuncture using ammonium
heparin syringes (MonovetteW, Sarstedt). Preadapted cell
suspension (100 μl) was inoculated into 25 ml of fresh
whole human blood and incubated for 0, 15, 30 and
60 min at 37°C in semi-aerated cultivation flasks. At
each time point, 2 volumes of 0.5% Triton X-100 were
added to break blood cells. Then the cells and blood
cells debris were collected by centrifugation at 1300 x g
for 3 min at 4°C. The pellet with yeast and blood cells
debris was transferred to a tube with 1 ml of cold water.
In order to separate yeast cells, a fast centrifugation
pulse (70 x g for 15 seconds) was performed. This treat-
ment precipitated blood cells debris maintaining only
yeast cells in the supernatant. This supernatant was cen-
trifuged at 1300 x g for 2 minutes at 4°C and the result-
ing pellet was immediately frozen in liquid nitrogen.
Control samples (time point 0) were treated exactly the
same way as the other samples to exclude variations due
sample manipulation in the transcriptomic data.RNA extraction and labeling
Frozen cells were lysed and homogenized by vortexing
in LETS buffer (10 mM Tris pH 7.4, 10 mM lithium-
EDTA, 100 mM lithium chloride, 1.0% lithium lauryl
sulfate) with acid-washed glass beads (0.4 – 0.6 mm;
Sigma-Aldrich) for 3 min, and total RNA was extracted
using phenol:chloroform RNA method [47]. mRNA was
amplified using Low RNA Input Fluorescent Linear
Amplification Kit (Agilent Technologies) according to
the manufacturer’s instructions. The amplification is
divided in two steps: a first step to synthesize cDNA
using oligo (dT) primer and a second step to synthesize
cRNA. The amplified cRNA obtained was purified using
RNeasy kit (Qiagen) following the instructions. cDNA
for transcriptional profiling was produced by incubating
1.5 μg (16.5 μl) amplified cRNA with 1 μl (0.4 μg/μl)
random hexamers (Agilent) at 70°C for 5 min. After add-
ing 1x first strand buffer, 12 mM DTT, 500 μM dATP,
500 μM dCTP, 500 μM dGTP, 160 μM dTTP (Fermen-
tas), 330 μM aminoallyl- dUTP (Fermentas), 10 U ribo-
nuclease inhibitor (Invitrogen) and 400 U SuperScript
III reverse transcriptase (Invitrogen) the mix was incu-
bated for 16 hours at 50°C. cDNA obtained was purified
using MinElute PCR Purification kit (Qiagen). Labeling
reaction was produced incubating 1.5-2 μg of
aminoallyl-cDNA with 3 μl of Cy3 and Cy5 fluorophores
(Amersham) at basic pH (0.2 M Na2CO3, pH 9) for
2 hours at room temperature. Labeled cDNA was puri-
fied using the same kit mentioned above.
Microarray hybridization and analysis
For transcript profiling, S. cerevisiae microarrays were
used, which were synthesized in duplicate on glass by
Microarray Center of University Health Network
(Canada), comprising 6,240 yeast ORFs. Microarrays
were prehybridized for 45 min at 42°C in 3 x SSC
(0.15 M NaCl and 0.015 M sodium citrate), 0.1% (w/v)
SDS and 0.1 mg/ml BSA. Prehybridized microarrays
were washed twice with water, once with isopropanol
and then dried by centrifugation. Before hybridization,
equal quantities of Cy5- and Cy3-labelled cDNA, 50%
(v/v) formamide, 5 x SSC and 0.1% (w/v) SDS were
mixed, made up to a final volume of 60 μl with water
and denatured for 1 min at 95°C. The mixture was ap-
plied to the prehybridized microarrays, covered with a
Hybri-slip (60 x 24 mm; Sigma-Aldrich) and
hybridization took place for 16 hours in a humidified
chamber in a water bath at 42°C. Hybridized microarrays
were washed for 5 min at 42°C in 2 x SSC, 0.1% (w/v)
SDS, for 20 min at room temperatures in 0.1 x SSC,
0.1% (w/v) SDS, for 6 min at room temperatures in 0.1 x
SSC, and for 1 min at room temperatures in 0.01 x SSC.
Hybridized microarrays were dried by centrifugation.
After washing, the microarrays were immediately
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10 μ m and data were analyzed using the GenePix Pro
6.1 software package (Axon Instruments). Hybridization
specificity was assured because no signal was observed
in control spots with bacterial or plants unspecific DNA.
Data were ratio-based normalized and processed using
Acuity 4.0 (Axon Instruments). False Discovery Rate
(FDR) of 5% was used to identify statistically significant
data. A cut-off rate of >2-fold was used to select for
induced genes. Functional group analysis was done using
GOstat, DAVID Database and GO term finder (SGD
database) online applications selecting for Bonferroni
corrected p-values < 0.05. mRNA level of selected genes
was confirmed by qRT-PCR. The microarray transcrip-
tomic data presented correspond to the average of three
biological replicates (separate cultures on different days)
including a dye swap. The microarray data was deposited
in ArrayExpress database with the accession number E-
TABM-1131.
qRT-PCR
To validate microarrays results, amplified RNA was con-
verted to cDNA and mRNA level of seven genes, in dif-
ferent strains and conditions, was quantified by qRT-
PCR. 1 μg of RNA was mixed with 0.5 mM dNTPs, 50
pmol Oligo(dT) in 10 μl. The mix was heated to 65°C
for 5 min and chilled on ice. Then 10 mM DTT, 50U
RNAse inhibitor (Invitrogen), 1x First Strand Buffer
(Invitrogen) and water to 20 μl were added to the mix
and it was incubated 2 min at room temp. After adding
500 U Superscript III (Invitrogen), samples were incu-
bated at 42°C for 50 min and reaction was inactivated
15 min at 70°C. Agarose gel electrophoresis was done to
check nucleic acid contaminations. qRT-PCR was per-
formed with gene-specific primers (200 nM) (Additional
file 1: Table S6) in a 20 μl reaction, using the Light
Cycler Fast Start DNA Master PLUS SYBR green (Roche
Applied Science, Germany) in a LightCyclerW 2.0 System
(Roche Applied Science, Germany) device. All samples
were processed for melting curve analysis, amplification
efficiency and DNA concentration determination using
LightCyclerW 2.0 System. A mix of all samples and serial
dilutions (10-1 to 10-5) were used as standard curve.
Survival during oxidative stress
Strains were grown overnight in YPD at 30°C. After
adjusting to 1 x 106 cells/ml in PBS, 6 mM H2O2 (Pan-
reac) were added and samples were incubated for one
hour at 30°C with shaking. Dilutions 10-2 to 10-4 were
done and 100 μl from these dilutions were spread on
YPD plates, incubated for 48 h at 30°C and cfu were
counted. Survival was calculated as the ratio of treated
over untreated cells (time point 0 min). To compare re-
sistance to oxidative stress of D14, D14YAP1 andD14ΔYap1 strains cells were patched on YPD or YPD
with 2.5 mM H2O2 plates and let them grow for 48 h.
Each strain was tested at least in three independent
experiments. Data are represented as averages ± standard
error and statistical significance was determined using
Student’s t test (see Additional file 1: Table S5).Survival assay in human blood
To investigate the survival of yeast strains in blood, C.
albicans SC5314 and four S. cerevisiae strains were
assayed. Yeast strains were grown overnight in YPD
medium at 30°C. The cells were washed once and sus-
pended in PBS buffer (Phosphate-buffered saline:
150 mM NaCl, 16 mM Na2HPO4, 4 mM NaH2PO4, pH
7.4) at a density of 5 x 107 cells/ml. Human peripheral
venous blood was collected from healthy volunteers by
venipuncture using ammonium heparin syringes (Mono-
vetteW, Sarstedt). Yeast cells were inoculated (1:1 ratio
of yeast: leukocytes) in blood and incubated for 10
and 60 min at 37°C. At each time point, 100 μl of 10-2 to
10-4dilutions were spread on YPD plates and incubated
for 48 h at 30°C. Colony-forming units (cfu) were counted
and percentages of survival determined as follows: (cfu/
cfuplasma) x 100. Each strain was tested three times. Data
were represented as averages ± standard error.Additional files
Additional file 1: Table S1. Genes and statistical significance
(p-values) of the functional groups expressed at 15, 30 and 60 min of
incubation in blood in virulent strains (60 and D14) and non-virulent
(CECT 10.431 and W303). Table S2. Genes and statistical significance (p-
values) of the functional groups repressed at 30 min of incubation in
blood in virulent strains (60 and D14) and non-virulent (CECT 10431 and
W303). Table S4. qRT-PCR validation of transcriptomic data. Table S5.
Statistical pairwise comparisons of Figure 2. Table 6. Primers used in this
study.
Additional file 2: Table S3. Complete microarray dataset.
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